The researcher found that hereditary breast cancer is characterized by breast cancer susceptibility based on a germline mutation in one allele of a high penetrance susceptibility gene (such as BRCA1, BRCA2, CHEK 2, TP53, or PTEN). The gene discussed is BRCA2; the disease is breast carcinoma.